Conway Capital Management’s Olema Pharmaceuticals OLMA Stock Holding History

Conway Capital Management’s Portfolio OLMA Stock Details OLMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-10,000	Closed	-$149K	–	45
2026 Q1	$149K	Hold	10,000	–	–	0.07%	44
2025 Q4	$250K	Hold	10,000	–	–	0.11%	40
2025 Q3	$97.9K	Hold	10,000	–	–	0.04%	49
2025 Q2	$42.6K	Hold	10,000	–	–	0.02%	49
2025 Q1	$37.6K	Hold	10,000	–	–	0.02%	43
2024 Q4	$58.3K	Hold	10,000	–	–	0.03%	48
2024 Q3	$119K	Hold	10,000	–	–	0.06%	47
2024 Q2	$108K	Hold	10,000	–	–	0.05%	41
2024 Q1	$113K	Sell	10,000 -16,500	-62%	-$213K	0.06%	45
2023 Q4	$372K	Hold	26,500	–	–	0.24%	34
2023 Q3	$327K	Hold	26,500	–	–	0.24%	31
2023 Q2	$239K	Hold	26,500	–	–	0.17%	41
2023 Q1	$92K	Hold	26,500	–	–	0.08%	46
2022 Q4	$64.9K	Hold	26,500	–	–	0.07%	43
2022 Q3	$73.1K	Hold	26,500	–	–	0.07%	48
2022 Q2	$108K	Hold	26,500	–	–	0.1%	47
2022 Q1	$113K	Sell	26,500 -5,774	-18%	-$31.8K	0.07%	57
2021 Q4	$302K	Hold	32,274	–	–	0.18%	46
2021 Q3	$889K	Sell	32,274 -10,000	-24%	-$270K	0.6%	31
2021 Q2	$1.18M	Buy	+42,274	New	+$1.2M	0.81%	29

Other funds holding OLMA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

PBA

Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

Jupiter Topco New York $245B AUM

BCLSI

Bain Capital Life Sciences Investors Boston, Massachusetts $1.68B AUM 126.09% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return

Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

Conway Capital Management's OLMA Position: Q2 2026 in Review

Conway Capital Management sold out of Olema Pharmaceuticals (OLMA) in Q2 2026, closing a stake of 10,000 shares — an estimated $149K sold.

Conway Capital Management first reported a position in OLMA in Q2 2021 and held it in 20 quarters. The position peaked at $1.18M in Q2 2021. 186 funds tracked by Wall St. Rank hold OLMA as of Q2 2026.

Conway Capital Management reported no remaining Olema Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Conway Capital Management sold 10,000 Olema Pharmaceuticals shares in Q2 2026, an estimated $149K.
Conway Capital Management first reported a position in Olema Pharmaceuticals in Q2 2021 and held it in 20 quarters.
Conway Capital Management's Olema Pharmaceuticals position peaked at $1.18M in Q2 2021.
186 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q2 2026.

Based on Conway Capital Management's 13F filing for Q2 2026, filed 7 Aug 2026.